Drug-Device Combination Products Market Report, Growth Analysis 2021: Impact of COVID-19, Business Insights of Leading Players, Segments and Emerging Technologies 2027

 As per UnivDatos Market Insights, the Drug-Device Combination Products Market was valued at US$ X million in 2020 and is expected to reach US$ X million by 2027, registering a CAGR of X% during the forecast period (2021-2027).

The surge in the Drug-device combination products Market is due to the increasing prevalence of coronary diseases and the increasing interest of people to use home-based care services. In addition to this, the rising number of geriatric populations globally is also driving the growth of the market. For instance, according to World Population Ageing 2020 Highlights in 2020, there are an estimated 727 million persons aged 65 years or over worldwide in 2020. This number is projected to more than double by 2050, reaching over 1.5 billion persons. The share of older persons in the global population is expected to increase from 9.3% in 2020 to 16% in 2050. By mid-century, one in six people globally will be aged 65 years or older.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=6406

The report “Global Drug-device combination products Market: Current Analysis and Forecast (2020-2027)” by UnivDatos Market Insights delivers a comprehensive analysis of product, application, distribution channel, end-user, and region.

Global Drug-device combination products Market Segmentation

By Product:

• Drug-eluting stent  
• Infusion pump
• Photosensitizers
• Prefilled syringe
• Wound care Combination Products
• Orthopaedic Combination Products
• Drug-eluting balloon
• Inhalers
• Transdermal delivery system
• Others

By Application:

• Cardiovascular disease
• Diabetes
• Respiratory problem
• Cancer treatment
• Antimicrobial application
• Others

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By End-Users:

• Hospital & Clinic
• Ambulatory Surgery Centre
• Home Care Setting
• Others

By Region:

• North America

• United States
• Canada
• Rest of North America

• Europe

• France
• Germany
• Italy
• Spain
• United Kingdom
• Rest of Europe

• Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

• Rest of World

Based on product, the market has been further segmented into Drug-eluting stents, Infusion pumps, Photosensitizers, Prefilled syringes, Wound care Combination Products, Orthopedic Combination Products, Drug-eluting balloon, Inhalers, Transdermal delivery systems, and Others. The Transdermal delivery systems, segment generated the highest revenue in 2020. The market is expected to grow at a significant rate during the forecast period as the patch provides a controlled release of medication into the patient, usually via a porous membrane or through body heat melting thin layers of medication embedded in the adhesive. For example, in October 2019, Noven Pharmaceuticals received the FDA’s approval for its “Secuado” (asenapine) transdermal system. It is used for treating adults with schizophrenia.

Request To Download Sample of this Strategic Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=6406

Amongst applications, the market is divided into cardiovascular disease, diabetes, respiratory problem, cancer treatment, antimicrobial applications, and Others. The cardiovascular disease segment dominated the market due to the increasing awareness of people about new drug-device combination products. For instance, in March 2020, Abbott received CE Mark for its new “FlexNav” delivery system for the company's Portico transcatheter aortic valve implantation (TAVI) system.

Based on distribution channel, the market is bifurcated into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. The Retail Pharmacies segment accounted for the major revenue portion in 2020. Retail pharmacy is the most widely used distribution channel worldwide. Based on end-user, the market is bifurcated into Hospital & Clinic, Ambulatory Surgery Centre, Home Care Setting, and Others. The Hospital & Clinic segment accounted for the major revenue portion in 2020.

Additionally, this report also provides detailed analysis for major regions including North America, Europe, Asia-pacific, and the rest of the world. North America constitutes a major market for the drug-device combination products industry and generated maximum revenue in 2020. For instance, according to American Heart Association in 2019, nearly half of all U.S. adults have some type of cardiovascular disease and by 2025 more than 130 million adults, or 45.1% of the US, population would have cardiovascular disease.

For a Sample of the report browse through - https://univdatos.com/get-a-free-sample-form-php/?product_id=6406

Key players

The market is highly fragmented due to the presence of different large, small, and medium-scale players. The market for drug-device combination products is highly competitive. Some of the key players that hold major market share include companies are:

• Medtronic PLC
• Abbott Laboratories
• Smith & Nephew plc
• Boston Scientific Corporation
• GlaxoSmithKline plc
• Becton Dickinson and Company
• Johnson & Johnson
• Novartis AG
• Bayer AG
• Baxter International, Inc.

Table of Content –

1 Market Introduction

2 Research Methodology or Assumption

3 Market Synopsis

4 Executive Summary

5 Top Start-Ups Under Drug-Device Combination Products Industry

6 COVID-19 Impact

7 Global Drug-Device Combination Products Market Revenue

8 Market Insights by Product

9 Market Insights by Application

10 Market Insights by Distribution Channel

11 Market Insights by End-User

12 Market Insights by Region

13 Drug-Device Combination Products Market Dynamics

14 Legal & Regulatory Framework

15 Demand And Supply Side Analysis

16 Value Chain Analysis

17 Drug-Device Combination Products Market Opportunities

18 Drug-Device Combination Products Market Trends & Insights

19 Competitive Scenario

20 Company Profiled

21 Disclaimer

About Us:

UnivDatos Market Insights (UMI), is a passionate market research firm and a subsidiary of Universal Data Solutions. Rigorous secondary and primary research on the market is our USP, hence information presented in our reports is based on facts and realistic assumptions. We have worked with 200+ global clients, including some of the fortune 500 companies. Our clientele praises us for quality of insights, In-depth analysis, custom research abilities and detailed market segmentation.

Contact us:

UnivDatos Market Insights (UMI)

Email: sales@univdatos.com

Web: https://univdatos.com

Ph: +91 7838604911